CHC Healthcare Group

Taiwan Stock Exchange 4164.TW

CHC Healthcare Group EBITDA Margin for the year ending December 31, 2023: 32.02%

CHC Healthcare Group EBITDA Margin is 32.02% for the year ending December 31, 2023, a -8.88% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

CHC Healthcare Group EBITDA Margin for the year ending December 31, 2022 was 35.14%, a -14.14% change year over year.
CHC Healthcare Group EBITDA Margin for the year ending December 31, 2021 was 40.92%, a 6.38% change year over year.
CHC Healthcare Group EBITDA Margin for the year ending December 31, 2020 was 38.47%, a 17.89% change year over year.
CHC Healthcare Group EBITDA Margin for the year ending December 31, 2019 was 32.63%, a -7.37% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Taiwan Stock Exchange: 4164.TW

CHC Healthcare Group

CEO	Mr. Yee-Min Jen
IPO Date	Oct. 3, 2012
Location	Taiwan
Headquarters	No. 88, Xing'ai Road
Employees	160
Sector	Healthcare
Industries Medical Instruments Biotechnology Dental Care Drugstores & Retail Pharmacies Hospitals & Clinics Insurance Personal Care Telehealth

Description

CHC Healthcare Group, together with its subsidiaries, provides a range of healthcare management services in Taiwan and internationally. It sells, installs, maintains, leases, and distributes medical equipment. The company is also involved in the provision of business management consultation and education training; elderly care business; and radiation sterilization business. In addition, it offers a range of equipment in the areas of radiation oncology, neurology, medical imaging, ophthalmology, and surgery. The company was founded in 1977 and is headquartered in Taipei, Taiwan.

Key trends

Past 5 years